8.4. Analysis.
Comparison 8 Topical capsaicin versus vehicle, Outcome 4 B) Risk for at least one adverse event per participant; UP participants, cross‐over design.
Comparison 8 Topical capsaicin versus vehicle, Outcome 4 B) Risk for at least one adverse event per participant; UP participants, cross‐over design.